{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:52:14Z","timestamp":1790268734923,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T00:00:00Z","timestamp":1713225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Taibah University Medical Sciences"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jtumed.2024.04.004","type":"journal-article","created":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T12:06:21Z","timestamp":1714133181000},"page":"549-565","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Polymeric nanoparticles: A promising strategy for treatment of Alzheimer's disease"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1675-335X","authenticated-orcid":false,"given":"Yasmina S.M.","family":"Elmahboub","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0781-1127","authenticated-orcid":false,"given":"Amal A.","family":"Elkordy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtumed.2024.04.004_bib1","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jconrel.2010.11.033","article-title":"Neurotherapeutic applications of nanoparticles in Alzheimer's disease","volume":"152","author":"Sahni","year":"2011","journal-title":"J\u00a0Contr Release"},{"key":"10.1016\/j.jtumed.2024.04.004_bib2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jddst.2015.07.007","article-title":"The \u201cfate\u201d of polymeric and lipid nanoparticles for brain delivery and targeting: strategies and mechanism of blood\u2013brain barrier crossing and trafficking into the central nervous system","volume":"32","author":"Tosi","year":"2016","journal-title":"J\u00a0Drug Deliv Sci Technol"},{"key":"10.1016\/j.jtumed.2024.04.004_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1228679","article-title":"Recent progress of nanomedicine\u00a0in the treatment of Alzheimer's disease","volume":"11","author":"Hu","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jtumed.2024.04.004_bib4","article-title":"Update on Therapeutic potential of emerging nanoformulations of phytocompounds in Alzheimer's and Parkinson's disease","volume":"79","author":"Kanojia","year":"2023","journal-title":"J\u00a0Drug Deliv Sci Technol"},{"key":"10.1016\/j.jtumed.2024.04.004_bib5","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s13346-021-00940-7","article-title":"Intranasal drug delivery for treatment of Alzheimer's disease","volume":"11","author":"Fonseca","year":"2021","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.jtumed.2024.04.004_bib6","article-title":"Polymeric nanoparticles for nasal drug delivery to the brain: relevance to Alzheimer's disease","volume":"4","author":"Rabiee","year":"2021","journal-title":"Adv Ther (Weinh)"},{"key":"10.1016\/j.jtumed.2024.04.004_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ph13110394","article-title":"Treatment of Alzheimer's disease and blood\u2013brain barrier drug delivery","volume":"13","author":"Pardridge","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jtumed.2024.04.004_bib8","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/psyg.12944","article-title":"Aducanumab for the treatment of Alzheimer's disease: a systematic review","volume":"23","author":"Rahman","year":"2023","journal-title":"Psychogeriatrics"},{"key":"10.1016\/j.jtumed.2024.04.004_bib9","first-page":"115","article-title":"Aducanumab","volume":"44","author":"Khanna","year":"2023","journal-title":"Drugs Future"},{"key":"10.1016\/j.jtumed.2024.04.004_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.1042986","article-title":"The application of nanotechnology in treatment of Alzheimer's disease","volume":"10","author":"Cao","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.jtumed.2024.04.004_bib11","article-title":"Update on Therapeutic potential of emerging nanoformulations of phytocompounds in Alzheimer's and Parkinson's disease","volume":"79","author":"Kanojia","year":"2023","journal-title":"J\u00a0Drug Deliv Sci Technol"},{"key":"10.1016\/j.jtumed.2024.04.004_bib12","article-title":"Development of polymeric nanoparticles for blood\u2013brain barrier transfer\u2014strategies and challenges","volume":"8","author":"Zhang","year":"2021","journal-title":"Adv Sci"},{"key":"10.1016\/j.jtumed.2024.04.004_bib13","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20220324","article-title":"Impact of nanoparticles on amyloid \u03b2-induced Alzheimer's disease, tuberculosis, leprosy and cancer: a systematic review","volume":"43","author":"Chakraborty","year":"2023","journal-title":"Biosci Rep"},{"key":"10.1016\/j.jtumed.2024.04.004_bib14","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.2147\/IJN.S87148","article-title":"Nanotechnology-based drug delivery systems for the treatment of Alzheimer's disease","volume":"10","author":"Fonseca-Santos","year":"2015","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.jtumed.2024.04.004_bib15","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1021\/acschemneuro.1c00022","article-title":"Neuroprotective efficacy of Co-encapsulated rosiglitazone and vorinostat nanoparticle on streptozotocin induced mice model of Alzheimer disease","volume":"12","author":"Sarathlal","year":"2021","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.jtumed.2024.04.004_bib16","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.3109\/10717544.2016.1153748","article-title":"Pharmacological, toxicological and neuronal localization assessment of galantamine\/chitosan complex nanoparticles in rats: future potential contribution in Alzheimer's disease management","volume":"23","author":"Hanafy","year":"2016","journal-title":"Drug Delivery"},{"key":"10.1016\/j.jtumed.2024.04.004_bib17","doi-asserted-by":"crossref","first-page":"599","DOI":"10.4155\/tde.11.21","article-title":"Design and evaluation of chitosan nanoparticles as novel drug carrier for the delivery of rivastigmine to treat Alzheimer's disease","volume":"2","author":"Wilson","year":"2011","journal-title":"Ther Deliv"},{"key":"10.1016\/j.jtumed.2024.04.004_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.939855","article-title":"Functionalization strategies of polymeric nanoparticles for drug delivery in Alzheimer's disease: current trends and future perspectives","volume":"16","author":"La Barbera","year":"2022","journal-title":"Front Neurosci"},{"key":"10.1016\/j.jtumed.2024.04.004_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2020.00238","article-title":"Nanoformulations of herbal extracts in treatment of neurodegenerative disorders","volume":"8","author":"Moradi","year":"2020","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.jtumed.2024.04.004_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232112924","article-title":"Amyloid beta in aging and Alzheimer's disease","volume":"23","author":"Sehar","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtumed.2024.04.004_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1440-1681.2000.03200.x","article-title":"Alzheimer's disease and inflammation: a review of cellular and therapeutic mechanisms","volume":"27","author":"Halliday","year":"2000","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.jtumed.2024.04.004_bib22","first-page":"506","article-title":"Significance of native PLGA nanoparticles in the treatment of Alzheimer's disease pathology","volume":"17","author":"Anand","year":"2022","journal-title":"Bioact Mater"},{"key":"10.1016\/j.jtumed.2024.04.004_bib23","first-page":"433","article-title":"Increased serum beta-secretase 1 activity is an early marker of Alzheimer's disease","volume":"87","author":"Nicsanu","year":"2022","journal-title":"J\u00a0Alzheim Dis"},{"key":"10.1016\/j.jtumed.2024.04.004_bib24","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1755-5949.2010.00177.x","article-title":"The role of tau in Alzheimer's disease and related disorders","volume":"17","author":"Medeiros","year":"2011","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.jtumed.2024.04.004_bib25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.clinbiochem.2019.04.001","article-title":"Neuro-inflammation and anti-inflammatory treatment options for Alzheimer's disease","volume":"72","author":"Ozben","year":"2019","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jtumed.2024.04.004_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.939855","article-title":"Functionalization strategies of polymeric nanoparticles for drug delivery in Alzheimer's disease: current trends and future perspectives","volume":"16","author":"La Barbera","year":"2022","journal-title":"Front Neurosci"},{"key":"10.1016\/j.jtumed.2024.04.004_bib27","doi-asserted-by":"crossref","first-page":"9067","DOI":"10.3390\/ijms24109067","article-title":"Role of calcium modulation in the pathophysiology and treatment of Alzheimer's disease","volume":"24","author":"Baracaldo-Santamar\u00eda","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtumed.2024.04.004_bib28","doi-asserted-by":"crossref","first-page":"5900","DOI":"10.3390\/ijms22115900","article-title":"Elevating the levels of calcium ions exacerbate Alzheimer's disease via inducing the production and aggregation of \u03b2-amyloid protein and phosphorylated tau","volume":"22","author":"Guan","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtumed.2024.04.004_bib29","first-page":"506","article-title":"Significance of native PLGA nanoparticles in the treatment of Alzheimer's disease pathology","volume":"17","author":"Anand","year":"2022","journal-title":"Bioact Mater"},{"key":"10.1016\/j.jtumed.2024.04.004_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032616","article-title":"Curcumin loaded-PLGA nanoparticles conjugated with Tet-1 peptide for potential use in Alzheimer's disease","volume":"7","author":"Mathew","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jtumed.2024.04.004_bib31","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1021\/jf0603533","article-title":"Molecular orbital basis for yellow curry spice curcumin's prevention of Alzheimer's disease","volume":"54","author":"Balasubramanian","year":"2006","journal-title":"J\u00a0Agric Food Chem"},{"key":"10.1016\/j.jtumed.2024.04.004_bib32","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1080\/10611860400015936","article-title":"Nanoparticle surface charges alter blood\u2013brain barrier integrity and permeability","volume":"12","author":"Lockman","year":"2004","journal-title":"J\u00a0Drug Target"},{"key":"10.1016\/j.jtumed.2024.04.004_bib33","doi-asserted-by":"crossref","first-page":"9764","DOI":"10.1021\/acs.jafc.1c00569","article-title":"PLGA-PEG nanoparticles facilitate in\u00a0vivo anti-Alzheimer\u2019s effects of fucoxanthin, a marine carotenoid derived from edible Brown algae","volume":"69","author":"Yang","year":"2021","journal-title":"J\u00a0Agric Food Chem"},{"key":"10.1016\/j.jtumed.2024.04.004_bib34","doi-asserted-by":"crossref","first-page":"4866","DOI":"10.3390\/molecules25204866","article-title":"Use of biodegradable, chitosan-based nanoparticles in the treatment of Alzheimer's disease","volume":"25","author":"Manek","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.jtumed.2024.04.004_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14051003","article-title":"Novel luteolin-loaded chitosan decorated nanoparticles for brain-targeting delivery in a sporadic Alzheimer's disease mouse model: focus on antioxidant, anti-inflammatory, and amyloidogenic pathways","volume":"14","author":"Abbas","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jtumed.2024.04.004_bib36","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1016\/j.biomaterials.2013.02.003","article-title":"Lactoferrin-modified PEG-co-PCL nanoparticles for enhanced brain delivery of NAP peptide following intranasal administration","volume":"34","author":"Liu","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jtumed.2024.04.004_bib37","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1365-2273.1999.00223.x","article-title":"Nasal pH measurement: a reliable and repeatable parameter","volume":"24","author":"England","year":"1999","journal-title":"Clin Otolaryngol Allied Sci"},{"key":"10.1016\/j.jtumed.2024.04.004_bib38","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2147\/nedt.2007.3.2.211","article-title":"Rivastigmine in the treatment of patients with Alzheimer's disease","volume":"3","author":"M\u00fcller","year":"2007","journal-title":"Neuropsychiatric Dis Treat"},{"key":"10.1016\/j.jtumed.2024.04.004_bib39","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejps.2012.04.013","article-title":"Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting","volume":"47","author":"Fazil","year":"2012","journal-title":"Eur J Pharmaceut Sci"},{"key":"10.1016\/j.jtumed.2024.04.004_bib40","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jconrel.2021.11.007","article-title":"Block copolymers in Alzheimer's disease therapy: a perceptive to revolutionize biomaterials","volume":"340","author":"Revdekar","year":"2021","journal-title":"J\u00a0Contr Release"},{"key":"10.1016\/j.jtumed.2024.04.004_bib41","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.3390\/ijms23084153","article-title":"Crossing the blood-brain barrier: advances in nanoparticle technology for drug delivery in neuro-oncology","volume":"23","author":"Hersh","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtumed.2024.04.004_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15071977","article-title":"Recent advances in polycaprolactones for anticancer drug delivery","volume":"15","author":"Bhadran","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jtumed.2024.04.004_bib43","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s12640-020-00258-1","article-title":"Exploring the neuroprotective potential of rosiglitazone embedded nanocarrier system on streptozotocin induced mice model of Alzheimer's disease","volume":"39","author":"Sarathlal","year":"2021","journal-title":"Neurotox Res"},{"key":"10.1016\/j.jtumed.2024.04.004_bib44","article-title":"Intranasal delivery of chitosan decorated PLGA core\/shell nanoparticles containing flavonoid to reduce oxidative stress in the treatment of Alzheimer's disease","volume":"61","author":"Dhas","year":"2021","journal-title":"J\u00a0Drug Deliv Sci Technol"},{"key":"10.1016\/j.jtumed.2024.04.004_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202203182","article-title":"Intranasal\u00a0delivery of BACE1 siRNA and rapamycin by dual\u00a0targets modified nanoparticles for Alzheimer's disease therapy","volume":"18","author":"Yang","year":"2022","journal-title":"Small"}],"container-title":["Journal of Taibah University Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1658361224000325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1658361224000325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T23:10:48Z","timestamp":1718752248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1658361224000325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1658361224000325"],"URL":"https:\/\/doi.org\/10.1016\/j.jtumed.2024.04.004","relation":{},"ISSN":["1658-3612"],"issn-type":[{"value":"1658-3612","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polymeric nanoparticles: A promising strategy for treatment of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Taibah University Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtumed.2024.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}